
Analysts Viewpoint
Recent Insider Activity Could Benefit Supernus Pharmaceuticals Inc (SUPN)
Supernus Pharmaceuticals Inc’s recent filing unveils that its SVP, Chief Medical Officer Rubin Jonathan unloaded Company’s shares for reported $36292.0